Catherine O'Riordan

Catherine O'Riordan

Sanofi US - New Jersey / United States
Others
AD Scientific Index ID: 4392653
-
person_outline Catherine O'Riordan's MOST POPULAR ARTICLES
1-) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosisSH Cheng, RJ Gregory, J Marshall, S Paul, DW Souza, GA White, ...Cell 63 (4), 827-834, 199020661990
2-) PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivoCR O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Riordan, A Lachapelle, C Delgado, V Parkes, SC Wadsworth, ...Human gene therapy 10 (8), 1349-1358, 19994821999
3-) CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophyMA Passini, J Bu, EM Roskelley, AM Richards, SP Sardi, CR O’Riordan, ...The Journal of clinical investigation 120 (4), 1253-1264, 20103222010
4-) Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choiceH Romanczuk, CE Galer, J Zabner, G Barsomian, SC Wadsworth, ...Human gene therapy 10 (16), 2615-2626, 19991901999
5-) Analytical ultracentrifugation as an approach to characterize recombinant adeno-associated viral vectorsB Burnham, S Nass, E Kong, ME Mattingly, D Woodcock, A Song, ...Human gene therapy methods 26 (6), 228-242, 20151672015